CCL11 and diabetes mellitus: In a meta-analysis published in 2021, Pan et al. (36) reported that the concentrations of eotaxin-1 in type 2 DM patients were significantly higher than those in control individuals, while no difference in these concentrations was found between prediabetic patients and non-DM patients.